A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Myeloproliferative neoplasms are a varied group of disorders that can have prolonged chronic phases, but eventually accelerate and can transform into a secondary acute myeloid leukemia that is ultimately fatal. Triapine is a novel inhibitor of the M2 subunit of ribonucleotide reductase. Sequential i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zeidner, Joshua F., Karp, Judith E., Blackford, Amanda L., Smith, B. Douglas, Gojo, Ivana, Gore, Steven D., Levis, Mark J., Carraway, Hetty E., Greer, Jacqueline M., Ivy, S. Percy, Pratz, Keith W., McDevitt, Michael A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2014
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971077/
https://ncbi.nlm.nih.gov/pubmed/24362550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.097246
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak